Office of the Director, National Institutes of Health; Notice of Meeting, 17013-17014 [2017-06906]
Download as PDF
Federal Register / Vol. 82, No. 66 / Friday, April 7, 2017 / Notices
nlaroche on DSK30NT082PROD with NOTICES
help us prepare for the ICCR–11 meeting
that will be held July 12–14, 2017, in
Brasilia, Brazil.
DATES: The public meeting will be held
on May 25, 2017, from 2 p.m. to 4 p.m.
See the SUPPLEMENTARY INFORMATION
section for registration date and
information.
ADDRESSES: The public meeting will be
held at the Food and Drug
Administration, Center for Food Safety
and Applied Nutrition, 5001 Campus
Dr., Wiley Auditorium (first floor),
College Park, MD 20740.
FOR FURTHER INFORMATION CONTACT:
Jonathan Hicks, Office of Cosmetics and
Colors, Food and Drug Administration,
5001 Campus Dr. (HFS–125), College
Park, MD 20740, email: jonathan.hicks@
fda.hhs.gov, 240–402–1375.
SUPPLEMENTARY INFORMATION:
I. Background
The purpose of the multilateral
framework on the ICCR is to pave the
way for the removal of regulatory
obstacles to international trade while
maintaining global consumer protection.
The purpose of the meeting is to invite
public input on various topics
pertaining to the regulation of
cosmetics. We may use this input to
help us prepare for the ICCR–11 meeting
that will be held July 12–14, 2017, in
Brasilia, Brazil.
ICCR is a voluntary international
group of cosmetics regulatory
authorities from Brazil, Canada, the
European Union, Japan, and the United
States of America. These regulatory
authority members will enter into
constructive dialogue with their
relevant cosmetics industry trade
associations and public advocacy
groups. Currently, the ICCR members
are: The Brazilian Health Surveillance
Agency; Health Canada; the European
Commission Directorate-General for
Internal Market, Industry,
Entrepreneurship, and Small and
Medium-sized Enterprises; the Ministry
of Health, Labor, and Welfare of Japan;
and FDA. All decisions made by
consensus will be compatible with the
laws, policies, rules, regulations, and
directives of the respective
administrations and governments.
Members will implement and/or
promote actions or documents within
their own jurisdictions and seek
convergence of regulatory policies and
practices. Successful implementation
will need input from stakeholders.
II. Topics for Discussion at the Public
Meeting
We will make the agenda for the
public meeting available on the Internet
VerDate Sep<11>2014
14:52 Apr 06, 2017
Jkt 241001
at https://www.fda.gov/Cosmetics/
InternationalActivities/ICCR/
default.htm. Depending on the number
of requests for oral presentations, we
intend to have an agenda available by
May 18, 2017.
III. Participating in the Public Meeting
Registration: To register for the public
meeting, send registration information
(including your name, title, affiliation,
address, email, and telephone), to
Jonathan Hicks by May 11, 2017. If you
would like to listen to the meeting by
phone, please submit a request for a
dial-in number by May 11, 2017. If you
need special accommodations due to a
disability, please contact Jonathan Hicks
by May 18, 2016.
Requests for Oral Presentations: If you
wish to make an oral presentation, you
should notify Jonathan Hicks by May
11, 2017, and submit a brief statement
of the general nature of the evidence or
arguments that you wish to present,
your name, title, affiliation, address,
email, and telephone, and indicate the
approximate amount of time you need
to make your presentation. You may
present proposals for future ICCR
agenda items, data, information, or
views, in person or in writing, on issues
pending at the public meeting. There
will be no presentations by phone. Time
allotted for oral presentations may be
limited to 10 minutes or less for each
presenter.
Transcripts: Please be advised that as
soon as a transcript of the public
meeting is available, it will be accessible
at https://www.regulations.gov. It may
also be viewed at the Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20850.
Dated: April 3, 2017.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2017–06938 Filed 4–6–17; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct;
Correction
Office of the Secretary, HHS.
Correction of notice.
AGENCY:
ACTION:
This document corrects an
error that appeared in the notice
published in the June 8, 2016, Federal
Register entitled ‘‘Findings of Research
Misconduct.’’
DATES:
SUMMARY:
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
17013
Effective Date: April 7, 2017.
Applicability Date: The correction
notice is applicable for the Findings of
Research Misconduct notice published
on June 8, 2016.
FOR FURTHER INFORMATION CONTACT: Ms.
Karen Gorirossi at 240–453–8800.
SUPPLEMENTARY INFORMATION:
I. Background
In FR Doc. 2016–13541 of June 8,
2016 (81 FR 36932–36933), there was a
typographical error involving one of the
papers cited in the notice. The error is
identified and corrected in the
Correction of Errors section below.
II. Correction of Errors
In FR Doc. 2016–13541 of June 8,
2016 (81 FR 36932–36933), make the
following correction:
1. On page 36932, third column, in FR
Doc. 2016–13541, second to last
paragraph, line 5, change ‘‘August’’ to
‘‘December’’ so that the text reads
‘‘falsified twenty-four (24) fluorescent
image panels by drawing staining in
Photoshop and falsely labeling them in
Figures 5B, 5C, 5D, 5E, 7A, 7B, 7D, 8A,
8B, 9A, and 9B in the December 2015
Development paper and included some
of the same images in four (4) figures in
the ASCB 2015 poster and in two (2)
figures in the MARZ 2015 poster’’
Dated: March 30, 2017.
Kathryn Partin,
Director, Office of Research Integrity.
[FR Doc. 2017–07006 Filed 4–6–17; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the meeting of the
Council of Councils.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting Web site (https://
videocast.nih.gov).
A portion of the meeting will be
closed to the public in accordance with
E:\FR\FM\07APN1.SGM
07APN1
17014
Federal Register / Vol. 82, No. 66 / Friday, April 7, 2017 / Notices
nlaroche on DSK30NT082PROD with NOTICES
the provisions set forth in sections
552b(c)(4), and 552b(c)(6), Title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Council of Councils.
Open: May 26, 2017.
Time: 8:15 a.m. to 11:15 a.m.
Agenda: Call to Order and Introductions;
Announcements and Updates; History of the
Knockout Mouse Program (KOMP); KOMP2
. . . A translational scientific resource to
catalyze biomedical research and accelerate
precision medicine; Background on NIH and
Federal Budget Process; Progress and Plans at
the NIA; Discussion.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Closed: May 26, 2017.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: Review of Grant Applications.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Open: May 26, 2017.
Time: 1:00 p.m. to 3:45 p.m.
Agenda: A study of possible bias
concerning race, gender, seniority and
institution and within the peer review
process; Common Fund Diversity Program—
Introduction and Update and Discussion;
Coming into Focus—The NIH and Health
Research in Tribal Nations; Closing Remarks.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Franziska Grieder, D.V.M.,
Ph.D., Executive Secretary, Director, Office of
Research Infrastructure Programs, Division of
Program Coordination, Planning, and
Strategic Initiatives, Office of the Director,
NIH, 6701 Democracy Boulevard, Room 948,
Bethesda, MD 20892, GriederF@mail.nih.gov,
301–435–0744.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Council of Council’s home page at https://
VerDate Sep<11>2014
14:52 Apr 06, 2017
Jkt 241001
dpcpsi.nih.gov/council/ where an agenda
will be posted before the meeting date.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: April 3, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06906 Filed 4–6–17; 8:45 am]
BILLING CODE 4140–01–P
Time: 1:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Yong Gao, Ph.D., Scientific
Review Officer, Scientific Review Program,
Division of Extramural Activities, Room
#3G13B, National Institutes of Health/NIAID,
5601 Fishers Lane, MSC 9823, Rockville, MD
20892–7616, (240) 669–5048,
yong.gao@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 3, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06969 Filed 4–6–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: May 1, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Raymond R. Schleef,
Ph.D., Senior Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, Room 3E61, National
Institutes of Health/NIAID, 5601 Fishers
Lane, MSC 9823, Bethesda, MD 20892–9823,
(240) 669–5019, schleefrr@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Rapid Assessment of Zika
Virus (ZIKV) Complications (R21).
Date: May 3–4, 2017.
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
National Institutes of Health
Office of the Secretary: Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Interagency Pain Research Coordinating
Committee (IPRCC).
The meeting will be open to the
public.
Name of Committee: Interagency Pain
Research Coordinating Committee.
Type of meeting: Open Meeting.
Date: May 5, 2017.
Time: 2:00 p.m. to 4:00 p.m. *Eastern
Time*.
Agenda: The meeting will include
discussion of the Federal Pain Research
Strategy and science advances in pain
research.
Place: National Institutes of Health, 31
Center Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Call-In Number: 1–877–668–4493.
Public Access Code: 622 888 818.
Deadline: Submission of intent to submit
written/electronic statement for comments:
Monday, May 1, 2017, by 5:00 p.m. ET.
Contact Person: Linda L. Porter, Ph.D.,
Director, Office of Pain Policy, Officer of the
Director, National Institute of Neurological
Disorders and Stroke, NIH, 31 Center Drive,
Room 8A31, Bethesda, MD 20892, Phone:
(301) 451–4460, Email: Linda.Porter@nih.gov.
Please Note: Any member of the public
interested in submitting written comments to
the Committee must notify the Contact
Person listed on this notice by 5:00 p.m. ET
on Monday, May 1, 2017, with their request.
Interested individuals and representatives of
organizations must submit a written/
E:\FR\FM\07APN1.SGM
07APN1
Agencies
[Federal Register Volume 82, Number 66 (Friday, April 7, 2017)]
[Notices]
[Pages 17013-17014]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06906]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of
the Council of Councils.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting. The open session will be
videocast and can be accessed from the NIH Videocasting and Podcasting
Web site (https://videocast.nih.gov).
A portion of the meeting will be closed to the public in accordance
with
[[Page 17014]]
the provisions set forth in sections 552b(c)(4), and 552b(c)(6), Title
5 U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Council of Councils.
Open: May 26, 2017.
Time: 8:15 a.m. to 11:15 a.m.
Agenda: Call to Order and Introductions; Announcements and
Updates; History of the Knockout Mouse Program (KOMP); KOMP2 . . . A
translational scientific resource to catalyze biomedical research
and accelerate precision medicine; Background on NIH and Federal
Budget Process; Progress and Plans at the NIA; Discussion.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD
20892.
Closed: May 26, 2017.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: Review of Grant Applications.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD
20892.
Open: May 26, 2017.
Time: 1:00 p.m. to 3:45 p.m.
Agenda: A study of possible bias concerning race, gender,
seniority and institution and within the peer review process; Common
Fund Diversity Program--Introduction and Update and Discussion;
Coming into Focus--The NIH and Health Research in Tribal Nations;
Closing Remarks.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Franziska Grieder, D.V.M., Ph.D., Executive
Secretary, Director, Office of Research Infrastructure Programs,
Division of Program Coordination, Planning, and Strategic
Initiatives, Office of the Director, NIH, 6701 Democracy Boulevard,
Room 948, Bethesda, MD 20892, GriederF@mail.nih.gov, 301-435-0744.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Council of Council's home
page at https://dpcpsi.nih.gov/council/ where an agenda will be
posted before the meeting date.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: April 3, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-06906 Filed 4-6-17; 8:45 am]
BILLING CODE 4140-01-P